Featured on CNN: First human trial of potential antibody treatment for Covid-19 begins
2020-06-02
"Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat Covid-19... The treatment was created in collaboration with AbCellera, a biotechnology company based in Canada."
Read full coverage on CNN.
